Literature DB >> 34177237

COVID-19 Vaccine in Veterans with Multiple Sclerosis: Protect the Vulnerable.

Francesca Bagnato1, Mitchell Wallin1.   

Abstract

Older veterans with progressive MS and associated comorbidities are at higher risk of death should they be infected by COVID-19 and we urge health care providers to educate every veteran about the benefits of being vaccinated against COVID-19.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID： 34177237      PMCID： PMC8221823          DOI： 10.12788/fp.0113

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  15 in total

1.  COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.

Authors:  Anat Achiron; Mark Dolev; Shay Menascu; Daniela-Noa Zohar; Sapir Dreyer-Alster; Shmuel Miron; Emanuel Shirbint; David Magalashvili; Shlomo Flechter; Uri Givon; Diana Guber; Yael Stern; Michael Polliack; Rina Falb; Michael Gurevich
Journal:  Mult Scler       Date:  2021-04-15       Impact factor: 6.312

Review 2.  Effects of MS disease-modifying therapies on responses to vaccinations: A review.

Authors:  John Robert Ciotti; Manouela V Valtcheva; Anne Haney Cross
Journal:  Mult Scler Relat Disord       Date:  2020-08-01       Impact factor: 4.339

3.  An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Authors:  Lisa A Jackson; Evan J Anderson; Nadine G Rouphael; Paul C Roberts; Mamodikoe Makhene; Rhea N Coler; Michele P McCullough; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian McDermott; Britta Flach; Nicole A Doria-Rose; Kizzmekia S Corbett; Kaitlyn M Morabito; Sijy O'Dell; Stephen D Schmidt; Phillip A Swanson; Marcelino Padilla; John R Mascola; Kathleen M Neuzil; Hamilton Bennett; Wellington Sun; Etza Peters; Mat Makowski; Jim Albert; Kaitlyn Cross; Wendy Buchanan; Rhonda Pikaart-Tautges; Julie E Ledgerwood; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-07-14       Impact factor: 91.245

Review 4.  Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases.

Authors:  Nora Möhn; Franz F Konen; Refik Pul; Christoph Kleinschnitz; Harald Prüss; Torsten Witte; Martin Stangel; Thomas Skripuletz
Journal:  J Clin Med       Date:  2020-12-16       Impact factor: 4.241

5.  Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

Authors:  Alicia T Widge; Nadine G Rouphael; Lisa A Jackson; Evan J Anderson; Paul C Roberts; Mamodikoe Makhene; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian B McDermott; Britta Flach; Bob C Lin; Nicole A Doria-Rose; Sijy O'Dell; Stephen D Schmidt; Kathleen M Neuzil; Hamilton Bennett; Brett Leav; Mat Makowski; Jim Albert; Kaitlyn Cross; Venkata-Viswanadh Edara; Katharine Floyd; Mehul S Suthar; Wendy Buchanan; Catherine J Luke; Julie E Ledgerwood; John R Mascola; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-12-03       Impact factor: 91.245

6.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

7.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.

Authors:  Sara E Oliver; Julia W Gargano; Heather Scobie; Megan Wallace; Stephen C Hadler; Jessica Leung; Amy E Blain; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; Jessica MacNeil; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-03-05       Impact factor: 17.586

8.  Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis.

Authors:  Amber Salter; Robert J Fox; Scott D Newsome; June Halper; David K B Li; Pamela Kanellis; Kathleen Costello; Bruce Bebo; Kottil Rammohan; Gary R Cutter; Anne H Cross
Journal:  JAMA Neurol       Date:  2021-06-01       Impact factor: 18.302

9.  First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.

Authors:  Julianne Gee; Paige Marquez; John Su; Geoffrey M Calvert; Ruiling Liu; Tanya Myers; Narayan Nair; Stacey Martin; Thomas Clark; Lauri Markowitz; Nicole Lindsey; Bicheng Zhang; Charles Licata; Amelia Jazwa; Mark Sotir; Tom Shimabukuro
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-26       Impact factor: 17.586

10.  Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

Authors:  Evan J Anderson; Nadine G Rouphael; Alicia T Widge; Lisa A Jackson; Paul C Roberts; Mamodikoe Makhene; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian B McDermott; Britta Flach; Bob C Lin; Nicole A Doria-Rose; Sijy O'Dell; Stephen D Schmidt; Kizzmekia S Corbett; Phillip A Swanson; Marcelino Padilla; Kathy M Neuzil; Hamilton Bennett; Brett Leav; Mat Makowski; Jim Albert; Kaitlyn Cross; Venkata Viswanadh Edara; Katharine Floyd; Mehul S Suthar; David R Martinez; Ralph Baric; Wendy Buchanan; Catherine J Luke; Varun K Phadke; Christina A Rostad; Julie E Ledgerwood; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-09-29       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.